July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.
FEops HEARTguide, which received CE mark earlier this year, is a procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. The current release includes workflows for TAVI and left atrial appendage occlusion (LAAO) procedures.
In addition to the Highlight of the year award, FEops HEARTguide was also starring in two best poster awards at CSI:
-
Best poster in TAVI, commented by Dowling and focusing on the impact of FEops HEARTguide on heart team decision making for TAVI in patients with bicuspid aortic valves; and
-
Best poster in LAA Occlusion, where A. Bavo, FEops, Belgium, presented the validation data for the LAAO workflow within FEops HEARTguide.
Dowling stated, “This award recognizes the outstanding work undertaken by the FEops team in developing patient-specific computer simulations for structural heart interventions.”
FEops HEARTguide cloud-based procedure planning environment uses advanced personalized computational modeling and simulation to provide clinicians and medical device manufacturers with insights into the interaction between transcatheter structural heart devices and specific patient anatomy – preoperatively. The current release includes TAVI and LAAO workflows. Such insights have the power to accelerate research and development of novel device-based solutions, as well as ultimately help to improve clinical outcomes in real-world hospital settings.
Read the article "FEops Closes Financing to Commercialize TAVIguide Service"
For more information: www.feops.com
April 09, 2024 
